Aging
Navigate
Research Paper|Volume 8, Issue 12|pp 3272—3297

Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination

Noor Dawany1,2, Elizabeth M Parzych1,3, Louise C Showe1, Hildegund CJ Ertl1
  • 1Wistar Institute, Philadelphia, PA 19104, USA
  • 2Present Address: The Children’s Hospital of Philadelphia, Department of Biomedical and Health Informatics, Philadelphia, PA 19104, USA
  • 3Present Address: Drexel University, School of Medicine, Philadelphia, PA 19104, USA
Received: September 20, 2016Accepted: October 26, 2016Published: November 9, 2016

Abstract

We analyzed gene expression profiles of young and aged mouse CD8+ T cells specific for the nucleoprotein (NP) of influenza A/PR8/34 virus. CD8+ T cells were stimulated either by the NP antigen expressed in its native form or fused into the herpes virus (HSV)-1 glycoprotein D (gD) protein, which blocks signaling through the immunoinhibitory B and T lymphocyte attenuator (BTLA) and CD160 pathways. We show that NP-specific CD8+ T cells from aged mice exhibit numerous differences in gene expression compared to NP-specific CD8+ T cells from young mice, including a significant reduction of expression in genes involved in T cell receptor (TcR) and CD28 signaling. We also show that these changes can be reversed in a sub-population (~50%) of the aged mice by a BTLA/CD160 checkpoint blockade. These results suggest that BTLA/CD160 checkpoint blockade has potential value as a vaccine additive to induce better CD8+ T cell responses in the aged.